Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 20, Issue 2, 2003, Pages 133-137

  Kato, Yasuchika ^a   Morimoto, Shin Ichiro ^a   Uemura, Akihisa ^a   Hiramitsu, Shinya ^a   Ito, Teruo ^b   Hishida, Hitoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Atrioventricular block; Cardiac function; Cardiac sarcoidosis; Steroid therapy

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERLIPIDEMIA; MALE; MEDICAL ASSESSMENT; MOON FACE; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; FEMALE; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 0037927511     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sehaumann J: Lymphogranulomatosis benign in the light of prolonged clinical observations and autopsy findings. Br J Derm 1936; 48: 399-446.
2. Matsui Y, Iwai K, Tachibana T: Clinicopathological study on fatal myocardial sarcoidosis. Ann NY Acad Sci 1976; 278: 455-69.
3. Tachibana T, Ohmori F, Ueda E: Clinical study on cardiac sarcoidosis. Ann NY Acad Sci 1986; 465: 530-42.
4. Lorell B, Alderman EL, Mason JW: Cardiac sarcoidosis: Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978; 42: 143-6.
5. Shammas RL, Movahed A: Successful treatment of myocardial sarcoidosis with steroids. Sarcoidosis 1994; 11: 37-9.
6. Ishikawa T, Kondoh H, Nakagawa S: Steroid therapy in cardiac sarcoidosis: Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest 1984; 85: 445-7.
7. Disease Control Division. Health Service Bureau, Ministry of Health and Welfare, Japan: A manual of diagnosis and therapy for the intractable disease for the general practitioner. Tokyo: Roppoh; 1990, p. 77 (in Japanese).
8. Yoshida Y, Morimoto S, Hiramitsu S, et al: Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997; 134: 382-6.
9. Larsen F, Pehrsson SK, Hammar N, et al: ECG-abnomalities in Japanese and Swedish patients with sarcoidosis. A comparison. Sarcoidosis Vasc Diff Lung Dis 2001: 18; 284-8.
10. Iwai K, Tachibana T, Takemura T: Pathological studies on sarcoidosis autopsy: Epidemiological features of 320 cases in Japan. Acta Patho Japonica 1993; 43: 372-6.
11. Martinetti M, Luisetti M, Cuccia M: HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diff Lung Dis 2002; 19: 83-95.
12. Uemura A, Morimoto S, Hiramitsu S, et al: Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999; 138: 299-302.
13. Baughman RP, Ohmichi M, Lower EE: Combination therapy for sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 2001; 18: 133-7.